Skip to main content

IE 11 is not supported. For an optimal experience visit our site on another browser.

Nov. 19, 202402:10

  • Fact vs. myth: What to know about potatoes, dairy-free milk, more

    05:07

  • Now Playing

    More than half of US adults are now eligible for Ozempic, Wegovy

    02:10

  • UP NEXT

    Food safety concerns grow following string of illness outbreaks

    02:41

  • Improve balance and build strength with this at-home workout

    03:39

  • E. coli outbreak linked to organic carrots sold in large retailers

    00:37

  • Should oily hair be washed more frequently? Beauty myths busted

    05:34

  • Elle Macpherson talks new book, struggles with addiction, more

    07:28

  • How to keep to healthy routines throughout the holiday season

    04:08

  • E. coli cases climb to more than 100 in McDonald’s onion outbreak

    02:18

  • Taraji P. Henson on mental health foundation inspired by late father

    11:09

  • ‘Full House’ star Dave Coulier reveals battle with cancer

    07:06

  • What to know about diabetes: Types, risk factors, new treatments

    05:38

  • Build strength at home this no-equipment workout

    02:58

  • James Van Der Beek opens up about battle with colorectal cancer

    02:17

  • Tips to overcome obstacles, stay motivated amid adversity, more

    04:19

  • Try these new diet and sleep habits for a pre-holiday glow up

    04:49

  • FDA moves to pull popular cold and flu medicines from shelves

    03:04

  • Try these tips to help stress less: Journaling, mindset shift, more

    03:57

  • What’s the best way to handle shorter and darker days?

    04:35

  • Adam Grant shares tips for navigating Election Day conversations

    05:12

About 140 million Americans, more than half of the nation’s adults, could be considered candidates for weight loss drugs Ozempic and Wegovy, according to a new study from JAMA Cardiology. NBC medical contributor Dr. Natalie Azar breaks down the latest for TODAY.

Source

Leave a Reply